nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—SLC22A2—Vinblastine—testicular cancer	0.0558	0.522	CbGbCtD
Pramipexole—SLC22A2—Cisplatin—testicular cancer	0.0511	0.478	CbGbCtD
Pramipexole—Body temperature increased—Etoposide—testicular cancer	0.000301	0.000337	CcSEcCtD
Pramipexole—Urinary tract infection—Doxorubicin—testicular cancer	0.000301	0.000337	CcSEcCtD
Pramipexole—Conjunctivitis—Doxorubicin—testicular cancer	0.000301	0.000337	CcSEcCtD
Pramipexole—Eye disorder—Methotrexate—testicular cancer	0.0003	0.000336	CcSEcCtD
Pramipexole—Tinnitus—Methotrexate—testicular cancer	0.000299	0.000335	CcSEcCtD
Pramipexole—Hypoaesthesia—Epirubicin—testicular cancer	0.000299	0.000335	CcSEcCtD
Pramipexole—Asthenia—Cisplatin—testicular cancer	0.000298	0.000334	CcSEcCtD
Pramipexole—Pharyngitis—Epirubicin—testicular cancer	0.000298	0.000334	CcSEcCtD
Pramipexole—Cardiac disorder—Methotrexate—testicular cancer	0.000298	0.000333	CcSEcCtD
Pramipexole—Sweating—Doxorubicin—testicular cancer	0.000297	0.000332	CcSEcCtD
Pramipexole—Urinary tract disorder—Epirubicin—testicular cancer	0.000297	0.000332	CcSEcCtD
Pramipexole—Oedema peripheral—Epirubicin—testicular cancer	0.000296	0.000331	CcSEcCtD
Pramipexole—Haematuria—Doxorubicin—testicular cancer	0.000295	0.00033	CcSEcCtD
Pramipexole—Connective tissue disorder—Epirubicin—testicular cancer	0.000295	0.00033	CcSEcCtD
Pramipexole—Urethral disorder—Epirubicin—testicular cancer	0.000294	0.00033	CcSEcCtD
Pramipexole—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000293	0.000328	CcSEcCtD
Pramipexole—Epistaxis—Doxorubicin—testicular cancer	0.000292	0.000327	CcSEcCtD
Pramipexole—Angiopathy—Methotrexate—testicular cancer	0.000291	0.000326	CcSEcCtD
Pramipexole—Sinusitis—Doxorubicin—testicular cancer	0.00029	0.000325	CcSEcCtD
Pramipexole—Immune system disorder—Methotrexate—testicular cancer	0.00029	0.000325	CcSEcCtD
Pramipexole—Visual impairment—Epirubicin—testicular cancer	0.000289	0.000324	CcSEcCtD
Pramipexole—Mediastinal disorder—Methotrexate—testicular cancer	0.000289	0.000324	CcSEcCtD
Pramipexole—Chills—Methotrexate—testicular cancer	0.000288	0.000322	CcSEcCtD
Pramipexole—Nausea—Ifosfamide—testicular cancer	0.000286	0.00032	CcSEcCtD
Pramipexole—Diarrhoea—Cisplatin—testicular cancer	0.000284	0.000318	CcSEcCtD
Pramipexole—Alopecia—Methotrexate—testicular cancer	0.000284	0.000317	CcSEcCtD
Pramipexole—Bradycardia—Doxorubicin—testicular cancer	0.000283	0.000317	CcSEcCtD
Pramipexole—Mental disorder—Methotrexate—testicular cancer	0.000281	0.000315	CcSEcCtD
Pramipexole—Eye disorder—Epirubicin—testicular cancer	0.000281	0.000314	CcSEcCtD
Pramipexole—Hypersensitivity—Etoposide—testicular cancer	0.00028	0.000314	CcSEcCtD
Pramipexole—Tinnitus—Epirubicin—testicular cancer	0.00028	0.000313	CcSEcCtD
Pramipexole—Erythema—Methotrexate—testicular cancer	0.000279	0.000313	CcSEcCtD
Pramipexole—Malnutrition—Methotrexate—testicular cancer	0.000279	0.000313	CcSEcCtD
Pramipexole—Flushing—Epirubicin—testicular cancer	0.000279	0.000312	CcSEcCtD
Pramipexole—Cardiac disorder—Epirubicin—testicular cancer	0.000279	0.000312	CcSEcCtD
Pramipexole—Rhinitis—Doxorubicin—testicular cancer	0.000279	0.000312	CcSEcCtD
Pramipexole—Hypoaesthesia—Doxorubicin—testicular cancer	0.000276	0.00031	CcSEcCtD
Pramipexole—Pharyngitis—Doxorubicin—testicular cancer	0.000276	0.000309	CcSEcCtD
Pramipexole—Urinary tract disorder—Doxorubicin—testicular cancer	0.000274	0.000307	CcSEcCtD
Pramipexole—Oedema peripheral—Doxorubicin—testicular cancer	0.000274	0.000306	CcSEcCtD
Pramipexole—Dysgeusia—Methotrexate—testicular cancer	0.000274	0.000306	CcSEcCtD
Pramipexole—Asthenia—Etoposide—testicular cancer	0.000273	0.000306	CcSEcCtD
Pramipexole—Connective tissue disorder—Doxorubicin—testicular cancer	0.000273	0.000306	CcSEcCtD
Pramipexole—Angiopathy—Epirubicin—testicular cancer	0.000272	0.000305	CcSEcCtD
Pramipexole—Urethral disorder—Doxorubicin—testicular cancer	0.000272	0.000305	CcSEcCtD
Pramipexole—Immune system disorder—Epirubicin—testicular cancer	0.000271	0.000304	CcSEcCtD
Pramipexole—Mediastinal disorder—Epirubicin—testicular cancer	0.000271	0.000303	CcSEcCtD
Pramipexole—Back pain—Methotrexate—testicular cancer	0.00027	0.000303	CcSEcCtD
Pramipexole—Chills—Epirubicin—testicular cancer	0.000269	0.000302	CcSEcCtD
Pramipexole—Pruritus—Etoposide—testicular cancer	0.000269	0.000301	CcSEcCtD
Pramipexole—Visual impairment—Doxorubicin—testicular cancer	0.000268	0.0003	CcSEcCtD
Pramipexole—Alopecia—Epirubicin—testicular cancer	0.000265	0.000297	CcSEcCtD
Pramipexole—Vomiting—Cisplatin—testicular cancer	0.000264	0.000296	CcSEcCtD
Pramipexole—Vision blurred—Methotrexate—testicular cancer	0.000263	0.000295	CcSEcCtD
Pramipexole—Mental disorder—Epirubicin—testicular cancer	0.000263	0.000295	CcSEcCtD
Pramipexole—Rash—Cisplatin—testicular cancer	0.000262	0.000293	CcSEcCtD
Pramipexole—Dermatitis—Cisplatin—testicular cancer	0.000262	0.000293	CcSEcCtD
Pramipexole—Malnutrition—Epirubicin—testicular cancer	0.000261	0.000293	CcSEcCtD
Pramipexole—Erythema—Epirubicin—testicular cancer	0.000261	0.000293	CcSEcCtD
Pramipexole—Diarrhoea—Etoposide—testicular cancer	0.00026	0.000292	CcSEcCtD
Pramipexole—Eye disorder—Doxorubicin—testicular cancer	0.00026	0.000291	CcSEcCtD
Pramipexole—Ill-defined disorder—Methotrexate—testicular cancer	0.000259	0.00029	CcSEcCtD
Pramipexole—Tinnitus—Doxorubicin—testicular cancer	0.000259	0.00029	CcSEcCtD
Pramipexole—Anaemia—Methotrexate—testicular cancer	0.000258	0.000289	CcSEcCtD
Pramipexole—Flushing—Doxorubicin—testicular cancer	0.000258	0.000289	CcSEcCtD
Pramipexole—Cardiac disorder—Doxorubicin—testicular cancer	0.000258	0.000289	CcSEcCtD
Pramipexole—Flatulence—Epirubicin—testicular cancer	0.000258	0.000288	CcSEcCtD
Pramipexole—Tension—Epirubicin—testicular cancer	0.000257	0.000287	CcSEcCtD
Pramipexole—Dysgeusia—Epirubicin—testicular cancer	0.000256	0.000287	CcSEcCtD
Pramipexole—Nervousness—Epirubicin—testicular cancer	0.000254	0.000284	CcSEcCtD
Pramipexole—Back pain—Epirubicin—testicular cancer	0.000253	0.000283	CcSEcCtD
Pramipexole—Angiopathy—Doxorubicin—testicular cancer	0.000252	0.000282	CcSEcCtD
Pramipexole—Malaise—Methotrexate—testicular cancer	0.000252	0.000282	CcSEcCtD
Pramipexole—Dizziness—Etoposide—testicular cancer	0.000252	0.000282	CcSEcCtD
Pramipexole—Muscle spasms—Epirubicin—testicular cancer	0.000251	0.000281	CcSEcCtD
Pramipexole—Immune system disorder—Doxorubicin—testicular cancer	0.000251	0.000281	CcSEcCtD
Pramipexole—Vertigo—Methotrexate—testicular cancer	0.000251	0.000281	CcSEcCtD
Pramipexole—Mediastinal disorder—Doxorubicin—testicular cancer	0.00025	0.00028	CcSEcCtD
Pramipexole—Leukopenia—Methotrexate—testicular cancer	0.00025	0.00028	CcSEcCtD
Pramipexole—Chills—Doxorubicin—testicular cancer	0.000249	0.000279	CcSEcCtD
Pramipexole—Nausea—Cisplatin—testicular cancer	0.000247	0.000276	CcSEcCtD
Pramipexole—Vision blurred—Epirubicin—testicular cancer	0.000246	0.000276	CcSEcCtD
Pramipexole—Alopecia—Doxorubicin—testicular cancer	0.000246	0.000275	CcSEcCtD
Pramipexole—Cough—Methotrexate—testicular cancer	0.000244	0.000273	CcSEcCtD
Pramipexole—Mental disorder—Doxorubicin—testicular cancer	0.000243	0.000273	CcSEcCtD
Pramipexole—Ill-defined disorder—Epirubicin—testicular cancer	0.000243	0.000272	CcSEcCtD
Pramipexole—Convulsion—Methotrexate—testicular cancer	0.000242	0.000271	CcSEcCtD
Pramipexole—Vomiting—Etoposide—testicular cancer	0.000242	0.000271	CcSEcCtD
Pramipexole—Erythema—Doxorubicin—testicular cancer	0.000242	0.000271	CcSEcCtD
Pramipexole—Malnutrition—Doxorubicin—testicular cancer	0.000242	0.000271	CcSEcCtD
Pramipexole—Anaemia—Epirubicin—testicular cancer	0.000242	0.000271	CcSEcCtD
Pramipexole—Agitation—Epirubicin—testicular cancer	0.00024	0.000269	CcSEcCtD
Pramipexole—Rash—Etoposide—testicular cancer	0.00024	0.000269	CcSEcCtD
Pramipexole—Dermatitis—Etoposide—testicular cancer	0.00024	0.000268	CcSEcCtD
Pramipexole—Headache—Etoposide—testicular cancer	0.000238	0.000267	CcSEcCtD
Pramipexole—Flatulence—Doxorubicin—testicular cancer	0.000238	0.000267	CcSEcCtD
Pramipexole—Chest pain—Methotrexate—testicular cancer	0.000238	0.000266	CcSEcCtD
Pramipexole—Myalgia—Methotrexate—testicular cancer	0.000238	0.000266	CcSEcCtD
Pramipexole—Arthralgia—Methotrexate—testicular cancer	0.000238	0.000266	CcSEcCtD
Pramipexole—Tension—Doxorubicin—testicular cancer	0.000237	0.000266	CcSEcCtD
Pramipexole—Dysgeusia—Doxorubicin—testicular cancer	0.000237	0.000265	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000236	0.000264	CcSEcCtD
Pramipexole—Malaise—Epirubicin—testicular cancer	0.000236	0.000264	CcSEcCtD
Pramipexole—Discomfort—Methotrexate—testicular cancer	0.000235	0.000263	CcSEcCtD
Pramipexole—Nervousness—Doxorubicin—testicular cancer	0.000235	0.000263	CcSEcCtD
Pramipexole—Vertigo—Epirubicin—testicular cancer	0.000235	0.000263	CcSEcCtD
Pramipexole—Syncope—Epirubicin—testicular cancer	0.000234	0.000262	CcSEcCtD
Pramipexole—Leukopenia—Epirubicin—testicular cancer	0.000234	0.000262	CcSEcCtD
Pramipexole—Back pain—Doxorubicin—testicular cancer	0.000234	0.000262	CcSEcCtD
Pramipexole—Muscle spasms—Doxorubicin—testicular cancer	0.000233	0.00026	CcSEcCtD
Pramipexole—Palpitations—Epirubicin—testicular cancer	0.000231	0.000259	CcSEcCtD
Pramipexole—Confusional state—Methotrexate—testicular cancer	0.00023	0.000257	CcSEcCtD
Pramipexole—Loss of consciousness—Epirubicin—testicular cancer	0.00023	0.000257	CcSEcCtD
Pramipexole—Cough—Epirubicin—testicular cancer	0.000228	0.000255	CcSEcCtD
Pramipexole—Vision blurred—Doxorubicin—testicular cancer	0.000228	0.000255	CcSEcCtD
Pramipexole—Convulsion—Epirubicin—testicular cancer	0.000226	0.000254	CcSEcCtD
Pramipexole—Infection—Methotrexate—testicular cancer	0.000226	0.000254	CcSEcCtD
Pramipexole—Nausea—Etoposide—testicular cancer	0.000226	0.000253	CcSEcCtD
Pramipexole—Hypertension—Epirubicin—testicular cancer	0.000226	0.000253	CcSEcCtD
Pramipexole—Ill-defined disorder—Doxorubicin—testicular cancer	0.000224	0.000251	CcSEcCtD
Pramipexole—Nervous system disorder—Methotrexate—testicular cancer	0.000224	0.00025	CcSEcCtD
Pramipexole—Anaemia—Doxorubicin—testicular cancer	0.000224	0.00025	CcSEcCtD
Pramipexole—Thrombocytopenia—Methotrexate—testicular cancer	0.000223	0.00025	CcSEcCtD
Pramipexole—Chest pain—Epirubicin—testicular cancer	0.000223	0.000249	CcSEcCtD
Pramipexole—Myalgia—Epirubicin—testicular cancer	0.000223	0.000249	CcSEcCtD
Pramipexole—Arthralgia—Epirubicin—testicular cancer	0.000223	0.000249	CcSEcCtD
Pramipexole—Agitation—Doxorubicin—testicular cancer	0.000222	0.000249	CcSEcCtD
Pramipexole—Anxiety—Epirubicin—testicular cancer	0.000222	0.000248	CcSEcCtD
Pramipexole—Skin disorder—Methotrexate—testicular cancer	0.000221	0.000248	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000221	0.000247	CcSEcCtD
Pramipexole—Hyperhidrosis—Methotrexate—testicular cancer	0.00022	0.000247	CcSEcCtD
Pramipexole—Discomfort—Epirubicin—testicular cancer	0.00022	0.000246	CcSEcCtD
Pramipexole—Malaise—Doxorubicin—testicular cancer	0.000218	0.000244	CcSEcCtD
Pramipexole—Dry mouth—Epirubicin—testicular cancer	0.000218	0.000244	CcSEcCtD
Pramipexole—Vertigo—Doxorubicin—testicular cancer	0.000217	0.000243	CcSEcCtD
Pramipexole—Anorexia—Methotrexate—testicular cancer	0.000217	0.000243	CcSEcCtD
Pramipexole—Syncope—Doxorubicin—testicular cancer	0.000217	0.000243	CcSEcCtD
Pramipexole—Leukopenia—Doxorubicin—testicular cancer	0.000217	0.000242	CcSEcCtD
Pramipexole—Confusional state—Epirubicin—testicular cancer	0.000215	0.000241	CcSEcCtD
Pramipexole—Palpitations—Doxorubicin—testicular cancer	0.000214	0.000239	CcSEcCtD
Pramipexole—Oedema—Epirubicin—testicular cancer	0.000213	0.000239	CcSEcCtD
Pramipexole—Hypotension—Methotrexate—testicular cancer	0.000213	0.000239	CcSEcCtD
Pramipexole—Loss of consciousness—Doxorubicin—testicular cancer	0.000213	0.000238	CcSEcCtD
Pramipexole—Infection—Epirubicin—testicular cancer	0.000212	0.000237	CcSEcCtD
Pramipexole—Cough—Doxorubicin—testicular cancer	0.000211	0.000236	CcSEcCtD
Pramipexole—Shock—Epirubicin—testicular cancer	0.00021	0.000235	CcSEcCtD
Pramipexole—Convulsion—Doxorubicin—testicular cancer	0.00021	0.000235	CcSEcCtD
Pramipexole—Nervous system disorder—Epirubicin—testicular cancer	0.000209	0.000234	CcSEcCtD
Pramipexole—Thrombocytopenia—Epirubicin—testicular cancer	0.000209	0.000234	CcSEcCtD
Pramipexole—Hypertension—Doxorubicin—testicular cancer	0.000209	0.000234	CcSEcCtD
Pramipexole—Tachycardia—Epirubicin—testicular cancer	0.000208	0.000233	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000208	0.000233	CcSEcCtD
Pramipexole—Skin disorder—Epirubicin—testicular cancer	0.000207	0.000232	CcSEcCtD
Pramipexole—Hyperhidrosis—Epirubicin—testicular cancer	0.000206	0.000231	CcSEcCtD
Pramipexole—Insomnia—Methotrexate—testicular cancer	0.000206	0.000231	CcSEcCtD
Pramipexole—Arthralgia—Doxorubicin—testicular cancer	0.000206	0.000231	CcSEcCtD
Pramipexole—Chest pain—Doxorubicin—testicular cancer	0.000206	0.000231	CcSEcCtD
Pramipexole—Myalgia—Doxorubicin—testicular cancer	0.000206	0.000231	CcSEcCtD
Pramipexole—Anxiety—Doxorubicin—testicular cancer	0.000205	0.00023	CcSEcCtD
Pramipexole—Paraesthesia—Methotrexate—testicular cancer	0.000205	0.000229	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000204	0.000229	CcSEcCtD
Pramipexole—Discomfort—Doxorubicin—testicular cancer	0.000203	0.000228	CcSEcCtD
Pramipexole—Anorexia—Epirubicin—testicular cancer	0.000203	0.000228	CcSEcCtD
Pramipexole—Dyspnoea—Methotrexate—testicular cancer	0.000203	0.000228	CcSEcCtD
Pramipexole—Somnolence—Methotrexate—testicular cancer	0.000203	0.000227	CcSEcCtD
Pramipexole—Dry mouth—Doxorubicin—testicular cancer	0.000201	0.000225	CcSEcCtD
Pramipexole—Dyspepsia—Methotrexate—testicular cancer	0.000201	0.000225	CcSEcCtD
Pramipexole—Hypotension—Epirubicin—testicular cancer	0.000199	0.000223	CcSEcCtD
Pramipexole—Confusional state—Doxorubicin—testicular cancer	0.000199	0.000223	CcSEcCtD
Pramipexole—Decreased appetite—Methotrexate—testicular cancer	0.000198	0.000222	CcSEcCtD
Pramipexole—Oedema—Doxorubicin—testicular cancer	0.000197	0.000221	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000197	0.00022	CcSEcCtD
Pramipexole—Fatigue—Methotrexate—testicular cancer	0.000197	0.00022	CcSEcCtD
Pramipexole—Infection—Doxorubicin—testicular cancer	0.000196	0.00022	CcSEcCtD
Pramipexole—Pain—Methotrexate—testicular cancer	0.000195	0.000218	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000194	0.000218	CcSEcCtD
Pramipexole—Shock—Doxorubicin—testicular cancer	0.000194	0.000217	CcSEcCtD
Pramipexole—Nervous system disorder—Doxorubicin—testicular cancer	0.000194	0.000217	CcSEcCtD
Pramipexole—Thrombocytopenia—Doxorubicin—testicular cancer	0.000193	0.000216	CcSEcCtD
Pramipexole—Insomnia—Epirubicin—testicular cancer	0.000193	0.000216	CcSEcCtD
Pramipexole—Tachycardia—Doxorubicin—testicular cancer	0.000193	0.000216	CcSEcCtD
Pramipexole—Skin disorder—Doxorubicin—testicular cancer	0.000192	0.000215	CcSEcCtD
Pramipexole—Paraesthesia—Epirubicin—testicular cancer	0.000192	0.000214	CcSEcCtD
Pramipexole—Hyperhidrosis—Doxorubicin—testicular cancer	0.000191	0.000214	CcSEcCtD
Pramipexole—Dyspnoea—Epirubicin—testicular cancer	0.00019	0.000213	CcSEcCtD
Pramipexole—Somnolence—Epirubicin—testicular cancer	0.00019	0.000212	CcSEcCtD
Pramipexole—Anorexia—Doxorubicin—testicular cancer	0.000188	0.000211	CcSEcCtD
Pramipexole—Feeling abnormal—Methotrexate—testicular cancer	0.000188	0.00021	CcSEcCtD
Pramipexole—Dyspepsia—Epirubicin—testicular cancer	0.000188	0.00021	CcSEcCtD
Pramipexole—Gastrointestinal pain—Methotrexate—testicular cancer	0.000186	0.000209	CcSEcCtD
Pramipexole—Decreased appetite—Epirubicin—testicular cancer	0.000185	0.000208	CcSEcCtD
Pramipexole—Hypotension—Doxorubicin—testicular cancer	0.000184	0.000207	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000184	0.000206	CcSEcCtD
Pramipexole—Fatigue—Epirubicin—testicular cancer	0.000184	0.000206	CcSEcCtD
Pramipexole—Pain—Epirubicin—testicular cancer	0.000182	0.000204	CcSEcCtD
Pramipexole—Constipation—Epirubicin—testicular cancer	0.000182	0.000204	CcSEcCtD
Pramipexole—Urticaria—Methotrexate—testicular cancer	0.000181	0.000203	CcSEcCtD
Pramipexole—Abdominal pain—Methotrexate—testicular cancer	0.00018	0.000202	CcSEcCtD
Pramipexole—Body temperature increased—Methotrexate—testicular cancer	0.00018	0.000202	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00018	0.000201	CcSEcCtD
Pramipexole—Insomnia—Doxorubicin—testicular cancer	0.000179	0.0002	CcSEcCtD
Pramipexole—Paraesthesia—Doxorubicin—testicular cancer	0.000177	0.000198	CcSEcCtD
Pramipexole—Dyspnoea—Doxorubicin—testicular cancer	0.000176	0.000197	CcSEcCtD
Pramipexole—Feeling abnormal—Epirubicin—testicular cancer	0.000176	0.000197	CcSEcCtD
Pramipexole—Somnolence—Doxorubicin—testicular cancer	0.000175	0.000196	CcSEcCtD
Pramipexole—Gastrointestinal pain—Epirubicin—testicular cancer	0.000174	0.000195	CcSEcCtD
Pramipexole—Dyspepsia—Doxorubicin—testicular cancer	0.000174	0.000195	CcSEcCtD
Pramipexole—Decreased appetite—Doxorubicin—testicular cancer	0.000172	0.000192	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00017	0.000191	CcSEcCtD
Pramipexole—Fatigue—Doxorubicin—testicular cancer	0.00017	0.000191	CcSEcCtD
Pramipexole—Urticaria—Epirubicin—testicular cancer	0.000169	0.00019	CcSEcCtD
Pramipexole—Constipation—Doxorubicin—testicular cancer	0.000169	0.000189	CcSEcCtD
Pramipexole—Pain—Doxorubicin—testicular cancer	0.000169	0.000189	CcSEcCtD
Pramipexole—Abdominal pain—Epirubicin—testicular cancer	0.000169	0.000189	CcSEcCtD
Pramipexole—Body temperature increased—Epirubicin—testicular cancer	0.000169	0.000189	CcSEcCtD
Pramipexole—Hypersensitivity—Methotrexate—testicular cancer	0.000168	0.000188	CcSEcCtD
Pramipexole—Asthenia—Methotrexate—testicular cancer	0.000164	0.000183	CcSEcCtD
Pramipexole—Feeling abnormal—Doxorubicin—testicular cancer	0.000163	0.000182	CcSEcCtD
Pramipexole—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000161	0.000181	CcSEcCtD
Pramipexole—Pruritus—Methotrexate—testicular cancer	0.000161	0.000181	CcSEcCtD
Pramipexole—Hypersensitivity—Epirubicin—testicular cancer	0.000157	0.000176	CcSEcCtD
Pramipexole—Urticaria—Doxorubicin—testicular cancer	0.000157	0.000176	CcSEcCtD
Pramipexole—Abdominal pain—Doxorubicin—testicular cancer	0.000156	0.000175	CcSEcCtD
Pramipexole—Body temperature increased—Doxorubicin—testicular cancer	0.000156	0.000175	CcSEcCtD
Pramipexole—Diarrhoea—Methotrexate—testicular cancer	0.000156	0.000175	CcSEcCtD
Pramipexole—Asthenia—Epirubicin—testicular cancer	0.000153	0.000171	CcSEcCtD
Pramipexole—Pruritus—Epirubicin—testicular cancer	0.000151	0.000169	CcSEcCtD
Pramipexole—Dizziness—Methotrexate—testicular cancer	0.000151	0.000169	CcSEcCtD
Pramipexole—Diarrhoea—Epirubicin—testicular cancer	0.000146	0.000163	CcSEcCtD
Pramipexole—Hypersensitivity—Doxorubicin—testicular cancer	0.000145	0.000163	CcSEcCtD
Pramipexole—Vomiting—Methotrexate—testicular cancer	0.000145	0.000162	CcSEcCtD
Pramipexole—Rash—Methotrexate—testicular cancer	0.000144	0.000161	CcSEcCtD
Pramipexole—Dermatitis—Methotrexate—testicular cancer	0.000144	0.000161	CcSEcCtD
Pramipexole—Headache—Methotrexate—testicular cancer	0.000143	0.00016	CcSEcCtD
Pramipexole—Asthenia—Doxorubicin—testicular cancer	0.000142	0.000159	CcSEcCtD
Pramipexole—Dizziness—Epirubicin—testicular cancer	0.000141	0.000158	CcSEcCtD
Pramipexole—Pruritus—Doxorubicin—testicular cancer	0.00014	0.000156	CcSEcCtD
Pramipexole—Vomiting—Epirubicin—testicular cancer	0.000136	0.000152	CcSEcCtD
Pramipexole—Nausea—Methotrexate—testicular cancer	0.000135	0.000152	CcSEcCtD
Pramipexole—Diarrhoea—Doxorubicin—testicular cancer	0.000135	0.000151	CcSEcCtD
Pramipexole—Rash—Epirubicin—testicular cancer	0.000135	0.000151	CcSEcCtD
Pramipexole—Dermatitis—Epirubicin—testicular cancer	0.000134	0.00015	CcSEcCtD
Pramipexole—Headache—Epirubicin—testicular cancer	0.000134	0.00015	CcSEcCtD
Pramipexole—Dizziness—Doxorubicin—testicular cancer	0.000131	0.000146	CcSEcCtD
Pramipexole—Nausea—Epirubicin—testicular cancer	0.000127	0.000142	CcSEcCtD
Pramipexole—Vomiting—Doxorubicin—testicular cancer	0.000126	0.000141	CcSEcCtD
Pramipexole—Rash—Doxorubicin—testicular cancer	0.000124	0.000139	CcSEcCtD
Pramipexole—Dermatitis—Doxorubicin—testicular cancer	0.000124	0.000139	CcSEcCtD
Pramipexole—Headache—Doxorubicin—testicular cancer	0.000124	0.000138	CcSEcCtD
Pramipexole—Nausea—Doxorubicin—testicular cancer	0.000117	0.000131	CcSEcCtD
